• Home
  • Blog

Call us today! +1 (352) 353-0052

Find our Location
info@derivatixcapital.com
Login

Login
Derivatix Capital ManagementDerivatix Capital Management
  • Home
  • Blog

Derivatix Quarterly Report: 2025-Q3 as of Sep. 30, 2025

Derivatix Quarterly Report: 2025-Q3 as of Sep. 30, 2025

Derivatix Quarterly Report: 2025-Q3 as of Sep. 30, 2025

October 26, 2025 Uncategorized

We hope this quarterly report finds you well. As we move through the final months of 2025, we’re pleased to share with you the latest insights and performance of the Derivatix fund.

Market Summary

The US equity markets delivered another strong quarter in 2025, extending the bullish momentum witnessed over the past year. The S&P 500 reached new all-time highs, powered by resilience in large-cap technology stocks, robust corporate earnings, and continued investor optimism about the US economic outlook. While inflation pressures moderated compared to 2024, shifting Federal Reserve signals and evolving interest rate expectations did inject renewed volatility at times. Sectors such as artificial intelligence, renewable energy, and healthcare remained bright spots, with increased capital flows driving gains. Nonetheless, select macro risks—including geopolitical tensions, pockets of persistent inflation, and shifts in global capital markets—kept risk management at the forefront for active managers.

 

Derivatix Fund Performance

As of Q3 2025, Derivatix has delivered a year-to-date return of 6.3%, with long-term returns of 312.5% since inception and an average annual return of 15.0%. While this year’s pace trails the S&P 500, our disciplined approach remains focused on consistent performance and risk management across cycles. Core strategy highlights include strong downside protection and reduced volatility compared to major benchmarks.

Share
0

You also might be interested in

Derivatix monthly report: Month 18 – as of Feb. 28, 2017

Feb 28, 2017

1. In February, the US market kept going up giving[...]

Derivatix Quarterly Report: 2020-Q1 as of Mar. 31st, 2020

Derivatix Quarterly Report: 2020-Q1 as of Mar. 31st, 2020

Apr 19, 2020

It is finally the spring time ladies and gentlemen. However,[...]

Derivatix Quarterly Report: 2019-Q4 as of Dec. 31st, 2019

Derivatix Quarterly Report: 2019-Q4 as of Dec. 31st, 2019

Jan 20, 2020

It is Jan. 2020. Happy new year everyone! After a[...]

Recent Posts

  • Derivatix Quarterly Report: 2025-Q3 as of Sep. 30, 2025
  • Derivatix Quarterly Report: 2025-Q2 as of June 30, 2025
  • Derivatix Quarterly Report: 2025-Q1 as of Mar. 31, 2025
  • Derivatix Quarterly Report: 2024-Q4 as of Dec. 31, 2024
  • Derivatix Quarterly Report: 2024-Q3 as of Sep. 30, 2024
  • Derivatix Quarterly Report: 2024-Q2 as of Jun. 30, 2024
  • Derivatix Quarterly Report: 2024-Q1 as of Mar. 31, 2024
  • Derivatix Quarterly Report: 2023-Q4 as of Dec. 31, 2023

Recent Comments

    Archives

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Recent Comments

    Find us on

    Contact Us

    We're not around right now. But you can send us an email and we'll get back to you, asap.

    Send Message

    Accredited Investors Only

    The information contained on this website is intended solely for informative purposes and does not represent a solicitation.

    By continuing to browse this site, you agree and confirm that you are an Accredited Investor.

    Contact Info

    • Derivatix Capital Management
    • +1 (352) 353-0052
    • info@derivatixcapital.com
    • derivatixcapital.com

    Fresh from blog

    • Derivatix Quarterly Report: 2025-Q3 as of Sep. 30, 2025
    • Derivatix Quarterly Report: 2025-Q2 as of June 30, 2025
    • Derivatix Quarterly Report: 2025-Q1 as of Mar. 31, 2025
    • Derivatix Quarterly Report: 2024-Q4 as of Dec. 31, 2024
    • Derivatix Quarterly Report: 2024-Q3 as of Sep. 30, 2024
    • Derivatix Quarterly Report: 2024-Q2 as of Jun. 30, 2024

    © 2025 — Derivatix Capital Management.

    • Home
    • Blog
    Prev

    Accredited Investors Only

    The information contained on this website is intended solely for informative purposes and does not represent a solicitation.

    By continuing to browse this site, you agree and confirm that you are an Accredited Investor.